ArticleFrontiers in cell and developmental biology2025
Screening for novel factors involved in mouse early embryonic development using inhibitor libraries.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mammalian early embryonic development is regulated by numerous factors, yet not all have been identified. Although omics approaches such as next-generation sequencing and proteomics provide powerful tools, screening methods using inhibitor libraries remain highly effective for identifying novel factors involved in embryonic development. To this end, we developed a novel screening system that combines ultra-superovulation technology with one-cell stage embryos cryopreservation in mice. Using this system, we screened 95 inhibitors to identify factors essential for the development of mouse fertilized eggs and identified 16 factors, including 5 previously known ones. Among the known factors, two were ATPases, and our data confirmed that inhibition of different ATPase types arrested embryonic development at distinct stages. In addition, we discovered novel regulators affecting various developmental stages, including a p53 activator (PRIMA-1), cathepsin D, CXCR2, and potassium channels (SK2 and SK3). Genome editing experiments involving knockout of the cathepsin D and CXCR2 genes further verified the arrest of embryonic development. These results demonstrate that our developed screening method can effectively identify novel factors involved in embryonic development. Application of this approach to additional inhibitor libraries and other species may facilitate the discovery of further species-specific regulators of early embryonic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.